Heritage Provider Network

Total investments

14

Average round size

43M

Portfolio companies

10

Rounds per year

0.54

Follow on index

0.29

Exits

1

Areas of investment
BiotechnologyAnalyticsHealth CareHealth DiagnosticsGeneticsMedical DeviceLife SciencePharmaceuticalTherapeuticsBioinformatics

Summary

Heritage Provider Network is the famous Corporate Investor, which was founded in 1996. The company was established in North America in United States. The main department of described Corporate Investor is located in the Northridge.

The current fund was established by Richard Merkin.

The top amount of exits for fund were in 2019. The top activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.

The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Heritage Provider Network, startups are often financed by Cambia Health Solutions, Wilson Sonsini Goodrich & Rosati, Rising Tide. The meaningful sponsors for the fund in investment in the same round are Wilson Sonsini Goodrich & Rosati, Rising Tide, Pillar Companies. In the next rounds fund is usually obtained by Celgene, Amgen Ventures, Alexandria Real Estate Equities.

The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 3 or 4 of the founder, the chance for it to get the investment is meager. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline IDx, Celsius Therapeutics, GNS Healthcare Among the most popular fund investment industries, there are Biotechnology, Pharmaceutical. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

Show more

Investments analytics

Analytics

Total investments
14
Lead investments
0
Exits
1
Rounds per year
0.54
Follow on index
0.29
Investments by industry
  • Biotechnology (10)
  • Health Care (8)
  • Genetics (5)
  • Medical Device (4)
  • Life Science (3)
  • Show 18 more
Investments by region
  • United States (13)
  • China (1)
Peak activity year
2018

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Alphamab Oncology 16 Nov 2018 Biotechnology, Health Care, Pharmaceutical, Therapeutics, Clinical Trials Early Stage Venture 100M Jiangsu, China, Gusu District
Celsius Therapeutics 24 Mar 2022 Biotechnology, Health Care, Genetics, Emergency Medicine Early Stage Venture 83M United States, Massachusetts, Cambridge
IQ Chef 01 Jun 2017 Information Technology Seed 0 Stockholm, Sweden, Stockholm County
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.